Cleveland Clinic study suggests steroid nasal sprays may help improve outcomes in severe COVID-19 disease

A recent Cleveland Clinic study found that patients who regularly use steroid nasal sprays are less likely to develop severe COVID-19-related disease, including a 20 to 25% lower risk of hospitalization, ICU admission and mortality. The study was published in Journal of Allergy and Clinical Immunology: In Practice.

from Breaking World Pharma News https://ift.tt/3F5CMkX